Osier Faith Ha, Feng Gaoqian, Boyle Michelle J, Langer Christine, Zhou Jingling, Richards Jack S, McCallum Fiona J, Reiling Linda, Jaworowski Anthony, Anders Robin F, Marsh Kevin, Beeson James G
Centre for Biomedical Research, The Burnet Institute, 85 Commercial Road, 3004 Melbourne, Victoria, Australia.
BMC Med. 2014 Jul 1;12:108. doi: 10.1186/1741-7015-12-108.
An understanding of the mechanisms mediating protective immunity against malaria in humans is currently lacking, but critically important to advance the development of highly efficacious vaccines. Antibodies play a key role in acquired immunity, but the functional basis for their protective effect remains unclear. Furthermore, there is a strong need for immune correlates of protection against malaria to guide vaccine development.
Using a validated assay to measure opsonic phagocytosis of Plasmodium falciparum merozoites, we investigated the potential role of this functional activity in human immunity against clinical episodes of malaria in two independent cohorts (n = 109 and n = 287) experiencing differing levels of malaria transmission and evaluated its potential as a correlate of protection.
Antibodies promoting opsonic phagocytosis of merozoites were cytophilic immunoglobulins (IgG1 and IgG3), induced monocyte activation and production of pro-inflammatory cytokines, and were directed against major merozoite surface proteins (MSPs). Consistent with protective immunity in humans, opsonizing antibodies were acquired with increasing age and malaria exposure, were boosted on re-infection, and levels were related to malaria transmission intensity. Opsonic phagocytosis was strongly associated with a reduced risk of clinical malaria in longitudinal studies in children with current or recent infections. In contrast, antibodies to the merozoite surface in standard immunoassays, or growth-inhibitory antibodies, were not significantly associated with protection. In multivariate analyses including several antibody responses, opsonic phagocytosis remained significantly associated with protection against malaria, highlighting its potential as a correlate of immunity. Furthermore, we demonstrate that human antibodies against MSP2 and MSP3 that are strongly associated with protection in this population are effective in opsonic phagocytosis of merozoites, providing a functional link between these antigen-specific responses and protection for the first time.
Opsonic phagocytosis of merozoites appears to be an important mechanism contributing to protective immunity in humans. The opsonic phagocytosis assay appears to be a strong correlate of protection against malaria, a valuable biomarker of immunity, and provides a much-needed new tool for assessing responses to blood-stage malaria vaccines and measuring immunity in populations.
目前尚缺乏对介导人类疟疾保护性免疫机制的了解,但这对于推进高效疫苗的研发至关重要。抗体在获得性免疫中起关键作用,但其保护作用的功能基础仍不清楚。此外,迫切需要疟疾保护性免疫的相关指标来指导疫苗研发。
我们使用经过验证的检测方法来测量恶性疟原虫裂殖子的调理吞噬作用,在两个经历不同疟疾传播水平的独立队列(n = 109和n = 287)中研究了这种功能活性在人类抗疟疾临床发作免疫中的潜在作用,并评估了其作为保护相关指标的潜力。
促进裂殖子调理吞噬作用的抗体是嗜细胞免疫球蛋白(IgG1和IgG3),可诱导单核细胞活化并产生促炎细胞因子,且针对主要的裂殖子表面蛋白(MSP)。与人类的保护性免疫一致,调理抗体随着年龄增长和疟疾暴露而获得,再次感染时会增强,其水平与疟疾传播强度相关。在对当前或近期感染儿童的纵向研究中,调理吞噬作用与临床疟疾风险降低密切相关。相比之下,标准免疫测定中针对裂殖子表面的抗体或生长抑制抗体与保护作用无显著关联。在包括多种抗体反应的多变量分析中,调理吞噬作用仍与预防疟疾显著相关,突出了其作为免疫相关指标的潜力。此外,我们证明,在该人群中与保护作用密切相关的针对MSP2和MSP3的人类抗体对裂殖子具有有效的调理吞噬作用,首次在这些抗原特异性反应与保护作用之间建立了功能联系。
裂殖子的调理吞噬作用似乎是促成人类保护性免疫的重要机制。调理吞噬作用检测似乎是预防疟疾的有力相关指标,是一种有价值的免疫生物标志物,并为评估对血期疟疾疫苗的反应和测量人群免疫力提供了急需的新工具。